Prosecution Insights
Browse Companies Examiners Firms Draft Your Response
Office Actions › Cardiff Oncology Inc. › 63729392
Last updated: April 22, 2026
Application No. 63/729,392

TREATMENT OF RAS-MUTATED METASTATIC COLORECTAL CANCER

Non-Final OA
Filed
Dec 08, 2024
Examiner
Art Unit
Tech Center
Assignee
Cardiff Oncology Inc.
OA Round
1 (Non-Final)
Grant Probability
Favorable
1-2
OA Rounds

Prosecution Timeline

Dec 08, 2024
Application Filed

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Ready to respond to this office action?

IP Author drafts your complete OA response — amendments, arguments, and claim strategy — in minutes, not days.

Start Drafting Your Response →

Data sourced from USPTO Patent File Wrapper (daily) and Office Action Archive (weekly). Analysis generated by IP Author.

Data: USPTO Patent File Wrapper (daily) • Office Action Archive (weekly) • 89M+ prosecution events

© 2026 IP Author — Browse Office Actions • Examiners • Companies • Firms

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month